Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Heart Failure

  Free Subscription

Articles published in
Circulation
    September 2021
  1. MORRIS AA, Khazanie P, Drazner MH, Albert NM, et al
    Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Sep 10:CIR0000000000001016. doi: 10.1161/CIR.0000000000001016.
    >> Share

  2. DANIELS MJ, Fusi L, Semsarian C, Naidu SS, et al
    Myosin Modulation in Hypertrophic Cardiomyopathy and Systolic Heart Failure: Getting Inside the Engine.
    Circulation. 2021;144:759-762.
    >> Share

    August 2021
  3. PACKER M, Butler J, Zannad F, Filippatos G, et al
    Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
    Circulation. 2021 Aug 29. doi: 10.1161/CIRCULATIONAHA.121.056824.
    >> Share

  4. PACKER M, Zannad F, Anker SD
    Heart Failure and a Preserved Ejection Fraction: A Side-by-Side Examination of the PARAGON-HF and EMPEROR-Preserved Trials.
    Circulation. 2021 Aug 29. doi: 10.1161/CIRCULATIONAHA.121.056657.
    >> Share

  5. EZEKOWITZ JA, Zheng Y, Cohen-Solal A, Melenovsky V, et al
    Hemoglobin and Clinical Outcomes in the VerICiguaT Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA).
    Circulation. 2021 Aug 25. doi: 10.1161/CIRCULATIONAHA.121.056797.
    >> Share

  6. ANKER SD, Ponikowski P, Wanner C, Pfarr E, et al
    Kidney Function After Initiation and Discontinuation of Empagliflozin in Heart Failure Patients With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials.
    Circulation. 2021 Aug 16. doi: 10.1161/CIRCULATIONAHA.121.054669.
    >> Share

  7. KORF-KLINGEBIEL M, Reboll MR, Polten F, Weber N, et al
    Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca(2+)-ATPase Expression in Cardiomyocytes.
    Circulation. 2021 Aug 10. doi: 10.1161/CIRCULATIONAHA.120.053365.
    >> Share

    July 2021
  8. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    >> Share

  9. SAWICKI KT, Ardehali H
    Intravenous Iron Therapy in Heart Failure With Reduced Ejection Fraction: Tackling the Deficiency.
    Circulation. 2021;144:253-255.
    >> Share

  10. LEE MMY, McMurray JJV, Jhund PS, Petrie MC, et al
    Response by Lee et al to Letter Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)".
    Circulation. 2021;144:e40.
    >> Share

  11. SINGH JS, Struthers AD, Lang CC
    Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)".
    Circulation. 2021;144:e38-e39.
    >> Share

  12. FELKER GM, Butler J, Ibrahim NE, Pina IL, et al
    Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
    Circulation. 2021;144:180-182.
    >> Share

    June 2021
  13. BREATHETT K, Knapp SM, Carnes M, Calhoun E, et al
    Imbalance in Heart Transplant to Heart Failure Mortality Ratio Among African American, Hispanic, and White Patients.
    Circulation. 2021;143:2412-2414.
    >> Share

  14. MORRIS AA, Testani JM, Butler J
    Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Racial Differences and a Potential for Reducing Disparities.
    Circulation. 2021;143:2329-2331.
    >> Share


  15. Correction to: Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.
    Circulation. 2021;143:e1027.
    >> Share

  16. FELKER GM, Butler J, Januzzi JL Jr, Desai AS, et al
    Probabilistic Readjudication of Heart Failure Hospitalization Events in the PARAGON-HF Study.
    Circulation. 2021;143:2316-2318.
    >> Share

  17. BIRKS EJ, Rame JE, Cunningham C, Drakos SG, et al
    Response by Birks et al to Letters Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1017-e1018.
    >> Share

  18. JENSEN J, Omar M, Kistorp C, Tuxen C, et al
    Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic).
    Circulation. 2021;143:2208-2210.
    >> Share

  19. MEHMOOD M
    Letter by Mehmood Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1014.
    >> Share

  20. MOAYEDI Y, Runeckles K, Posada JD
    Letter by Moayedi et al Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1015-e1016.
    >> Share

    May 2021
  21. KAR S, Mack MJ, Lindenfeld J, Abraham WT, et al
    Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: The COAPT Trial.
    Circulation. 2021 May 27. doi: 10.1161/CIRCULATIONAHA.120.053061.
    >> Share

  22. LOPES RD, Alexander KP, Hochman JS, Maron DJ, et al
    Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e961-e962.
    >> Share

  23. MORGAN H, Clayton T, Perera D
    Letter by Morgan et al Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e959-e960.
    >> Share

  24. CARLEY AN, Maurya SK, Fasano M, Wang Y, et al
    Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart.
    Circulation. 2021;143:1797-1808.
    >> Share

    April 2021
  25. JOHANSSON I, Joseph P, Balasubramanian K, McMurray JJV, et al
    Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23,000 Patients from 40 Countries.
    Circulation. 2021 Apr 28. doi: 10.1161/CIRCULATIONAHA.120.050850.
    >> Share


  26. Correction to: Excessive O-GlcNAcylation Causes Heart Failure and Sudden Death.
    Circulation. 2021;143:e892.
    >> Share

  27. KANEKO H, Yano Y, Itoh H, Morita K, et al
    Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
    >> Share

  28. SEGAR MW, Jaeger BC, Patel KV, Nambi V, et al
    Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multi-Cohort Analysis.
    Circulation. 2021 Apr 13. doi: 10.1161/CIRCULATIONAHA.120.053134.
    >> Share

  29. JHUND PS, Ponikowski P, Docherty KF, Gasparyan SB, et al
    Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure with Reduced Ejection Fraction: An Analysis of DAPA-HF.
    Circulation. 2021 Apr 9. doi: 10.1161/CIRCULATIONAHA.121.053659.
    >> Share

  30. ROSENFELD LE, Enriquez AD
    The Cabana Trial and Heart Failure: Some Sun and Some Shade.
    Circulation. 2021;143:1391-1393.
    >> Share

    March 2021
  31. LOOMBA RS, Villarreal EG, Flores S
    Letter by Loomba et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
    Circulation. 2021;143:e755-e756.
    >> Share

  32. NAVARRO CASTELLANOS I, Dahdah N
    Letter by Navarro Castellanos and Dahdah Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
    Circulation. 2021;143:e759-e760.
    >> Share

  33. CARDENAS SURI H, Jimomila Bening D
    Letter by Cardenas Suri and Jimomila Bening Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
    Circulation. 2021;143:e757-e758.
    >> Share

  34. REN C, Qian M, Han C
    Letter by Ren et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
    Circulation. 2021;143:e761-e762.
    >> Share

  35. YU H, Zhang F, Yan P, Zhang S, et al
    LARP7 Protects Against Heart Failure by Enhancing Mitochondrial Biogenesis.
    Circulation. 2021 Mar 5. doi: 10.1161/CIRCULATIONAHA.120.050812.
    >> Share

    February 2021
  36. UMAPATHI P, Banerjee PS, Zachara NE, Abrol N, et al
    Excessive O - GlcNAcylation Causes Heart Failure and Sudden Death.
    Circulation. 2021 Feb 17. doi: 10.1161/CIRCULATIONAHA.120.051911.
    >> Share

  37. PACKER DL, Piccini JP, Monahan KH, Al-Khalidi HR, et al
    Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results from the CABANA Trial.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.050991.
    >> Share

  38. NASSIF ME, Qintar M, Windsor SL, Jermyn R, et al
    Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.052503.
    >> Share

    January 2021

  39. Correction to: Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from EMPEROR-Reduced.
    Circulation. 2021;143:e29.
    >> Share


  40. Correction to: Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
    Circulation. 2021;143:e30.
    >> Share

  41. KOSIBOROD M
    Diamonds in the Rough: The Incredible-but-True Story of Sodium Glucose Cotransporter 2 Inhibitors in Treatment of Heart Failure.
    Circulation. 2021;143:350-353.
    >> Share

  42. CARNICELLI AP, Mentz RJ
    Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: The Heart and Kidney Working Better Together.
    Circulation. 2021;143:322-325.
    >> Share

  43. HANG PZ, Zhao J
    Letter by Hang and Zhao Regarding Article, "Cardiac Overexpression of PDE4B Blunts beta-Adrenergic Response and Maladaptive Remodeling in Heart Failure".
    Circulation. 2021;143:e24-e25.
    >> Share

  44. VANDECASTEELE G, Mika D, Margaria JP, Ghigo A, et al
    Response by Vandecasteele et al to Letter Regarding Article, "Cardiac Overexpression of PDE4B Blunts beta-Adrenergic Response and Maladaptive Remodeling in Heart Failure".
    Circulation. 2021;143:e26-e27.
    >> Share

  45. BACKHAUS SJ, Lange T, George EF, Hellenkamp K, et al
    Exercise-Stress Real-time Cardiac Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: The HFpEF Stress Trial.
    Circulation. 2021 Jan 21. doi: 10.1161/CIRCULATIONAHA.120.051542.
    >> Share

  46. CHURCHILL TW, Li SX, Curreri L, Zern EK, et al
    Evaluation of 2 Existing Diagnostic Scores for Heart Failure With Preserved Ejection Fraction Against a Comprehensively Phenotyped Cohort.
    Circulation. 2021;143:289-291.
    >> Share

    December 2020
  47. MCMURRAY JJV, Packer M
    How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction? A Redefinition of Evidence-Based Medicine.
    Circulation. 2020 Dec 30. doi: 10.1161/CIRCULATIONAHA.120.052926.
    >> Share

  48. ZANNAD F, Cowie MR
    VERTIS-CV: More Evidence That Sodium Glucose Cotransporter 2 Inhibition Brings Rapid and Sustained Heart Failure Benefit.
    Circulation. 2020;142:2216-2218.
    >> Share

    November 2020
  49. EZEKOWITZ JA, Savu A, Welsh RC, McAlister FA, et al
    Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?
    Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.048015.
    >> Share

  50. SARMA S, Howden E, Lawley J, Samels M, et al
    Central Command and the Regulation of Exercise Heart Rate Response in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.048338.
    >> Share

  51. ALLEN LA, Venechuk G, McIlvennan CK, Page Ii RL, et al
    An Electronically Delivered, Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure with Reduced Ejection Fraction: The EPIC-HF Trial.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051863.
    >> Share


  52. Correction to: Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
    Circulation. 2020;142:e369.
    >> Share

  53. LI X, Xue Q, Wang M, Zhou T, et al
    Adherence to a Healthy Sleep Pattern and Incident Heart Failure: A Prospective Study of 408802 UK Biobank Participants.
    Circulation. 2020 Nov 16. doi: 10.1161/CIRCULATIONAHA.120.050792.
    >> Share

  54. LEE MMY, Brooksbank KJM, Wetherall K, Mangion K, et al
    Effect of Empagliflozin on Left Ventricular Volumes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF).
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.052186.
    >> Share

  55. ANKER SD, Butler J, Filippatos G, Khan MS, et al
    Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial.
    Circulation. 2020 Nov 11. doi: 10.1161/CIRCULATIONAHA.120.051824.
    >> Share

  56. GIERULA J, Lowry JE, Paton MF, Cole CA, et al
    Response by Gierula et al to Letter Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study".
    Circulation. 2020;142:e319-e320.
    >> Share

  57. LAU CP, Tse HF
    Letter by Lau and Tse Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study".
    Circulation. 2020;142:e317-e318.
    >> Share

  58. ALBERT CL, Carmona-Rubio AE, Weiss AJ, Procop GG, et al
    The Enemy Within: Sudden-Onset Reversible Cardiogenic Shock With Biopsy-Proven Cardiac Myocyte Infection by Severe Acute Respiratory Syndrome Coronavirus 2.
    Circulation. 2020;142:1865-1870.
    >> Share

  59. PATEL KV, Bahnson JL, Gaussoin SA, Johnson KC, et al
    Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
    Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050941.
    >> Share


  60. Correction to: Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
    Circulation. 2020;142:e316.
    >> Share

  61. HO JE, Redfield MM, Lewis GD, Paulus WJ, et al
    Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2020;142:1770-1780.
    >> Share

    October 2020
  62. HAHN VS, Knutsdottir H, Luo X, Bedi K, et al
    Myocardial Gene Expression Signatures in Human Heart Failure with Preserved Ejection Fraction.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050498.
    >> Share

  63. BIRKS EJ, Drakos SG, Patel SR, Lowes BD, et al
    A Prospective Multicentre Study of Myocardial Recovery Using Left Ventricular Assist Devices (REmission from Stage D Heart Failure: RESTAGE-HF): Medium Term and Primary Endpoint Results.
    Circulation. 2020 Oct 26. doi: 10.1161/CIRCULATIONAHA.120.046415.
    >> Share

  64. ZANNAD F, Ferreira JP, Pocock SJ, Zeller C, et al
    Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Reduced Trial.
    Circulation. 2020 Oct 23. doi: 10.1161/CIRCULATIONAHA.120.051685.
    >> Share

  65. PACKER M, Anker SD, Butler J, Filippatos GS, et al
    Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
    Circulation. 2020 Oct 21. doi: 10.1161/CIRCULATIONAHA.120.051783.
    >> Share

  66. THIBODEAU JT, Gorodeski EZ
    Telehealth for Uptitration of Guideline-Directed Medical Therapy in Heart Failure.
    Circulation. 2020;142:1507-1509.
    >> Share


  67. Correction to: Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Circulation. 2020;142:e234.
    >> Share


  68. Correction to: Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
    Circulation. 2020;142:e236.
    >> Share

  69. JHUND PS, Solomon SD, Docherty KF, Heerspink HJL, et al
    Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF.
    Circulation. 2020 Oct 12. doi: 10.1161/CIRCULATIONAHA.120.050391.
    >> Share

  70. SANDERS-VAN WIJK S, Tromp J, Beussink-Nelson L, Hage C, et al
    Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure with Preserved Ejection Fraction: Results from the PROMIS-HFpEF Study.
    Circulation. 2020 Oct 9. doi: 10.1161/CIRCULATIONAHA.120.045810.
    >> Share

  71. COSENTINO F, Cannon CP, Cherney DZI, Masiukiewicz U, et al
    Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.
    Circulation. 2020 Oct 7. doi: 10.1161/CIRCULATIONAHA.120.050255.
    >> Share

    September 2020
  72. TOBE SW, Poon S
    Angiotensin Receptor-Neprilysin Inhibitor Therapy for Heart Failure With Preserved Ejection Fraction Improves Renal Outcomes.
    Circulation. 2020;142:1246-1248.
    >> Share

  73. KHAN MS, Fonarow GC, McGuire DK, Hernandez AF, et al
    Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.
    Circulation. 2020;142:1205-1218.
    >> Share

  74. LI J, Tan Y, Passariello CL, Martinez EC, et al
    Signalosome-Regulated SRF Phosphorylation Determining Myocyte Growth in Width versus Length as a Therapeutic Target for Heart Failure.
    Circulation. 2020 Sep 16. doi: 10.1161/CIRCULATIONAHA.119.044805.
    >> Share

  75. GRODIN JL, Tang WHW
    Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney.
    Circulation. 2020;142:1055-1058.
    >> Share

  76. PARCHA V, Patel N, Kalra R, Arora G, et al
    Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial.
    Circulation. 2020;142:1018-1020.
    >> Share

  77. VERBRUGGE FH, Guazzi M, Testani JM, Borlaug BA, et al
    Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney.
    Circulation. 2020;142:998-1012.
    >> Share

  78. CHAN MY, Efthymios M, Tan SH, Pickering JW, et al
    Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Circulation. 2020 Sep 4. doi: 10.1161/CIRCULATIONAHA.119.045158.
    >> Share

  79. DOCHERTY KF, Jhund PS, Anand I, Bengtsson O, et al
    Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.
    Circulation. 2020 Sep 4. doi: 10.1161/CIRCULATIONAHA.120.047480.
    >> Share

  80. DURSTENFELD MS, Hsue PY
    An Unusual, Reversible Cause of Acute High-Output Heart Failure Complicated by Refractory Shock.
    Circulation. 2020;142:901-905.
    >> Share

    August 2020
  81. MORDI NA, Mordi IR, Singh JS, McCrimmon RJ, et al
    Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
    Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.048739.
    >> Share

  82. LOPES RD, Alexander KP, Stevens SR, Reynolds HR, et al
    Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
    Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050304.
    >> Share

  83. MC CAUSLAND FR, Lefkowitz MP, Claggett B, Anavekar NS, et al
    Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2020 Aug 17. doi: 10.1161/CIRCULATIONAHA.120.047643.
    >> Share

  84. CHEN F, Chen ZQ, Zhu JJ
    Letter by Chen et al Regarding Article, "Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study".
    Circulation. 2020;142:e67-e68.
    >> Share

  85. LEWIS AA, de Lemos JA
    Response by Lewis and de Lemos to Letter Regarding Article, "Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study".
    Circulation. 2020;142:e69-e70.
    >> Share

  86. SIMPSON JM, Newburger JW
    Multisystem Inflammatory Syndrome in Children in Association With COVID-19.
    Circulation. 2020;142:437-440.
    >> Share

    July 2020
  87. OMURA J, Habbout K, Shimauchi T, Wu WH, et al
    Identification of The Long Non-Coding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 23. doi: 10.1161/CIRCULATIONAHA.120.047626.
    >> Share

  88. JACKSON AM, Dewan P, Anand IS, Belohlavek J, et al
    Dapagliflozin and Diuretic Use in Patients with Heart Failure and Reduced Ejection Fraction in DAPA-HF.
    Circulation. 2020 Jul 16. doi: 10.1161/CIRCULATIONAHA.120.047077.
    >> Share

  89. JACKSON AM, Jhund PS, Solomon SD, McMurray JJV, et al
    Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF".
    Circulation. 2020;142:e5-e6.
    >> Share

  90. WU K, Zhao S
    Letter by Wu and Zhao Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF".
    Circulation. 2020;142:e3-e4.
    >> Share

    June 2020
  91. MOAZZAMI K, Wittbrodt MT, Lima BB, Nye JA, et al
    Higher Activation of the Rostromedial Prefrontal Cortex during Mental Stress Predicts Major Cardiovascular Disease Events in Individuals with Coronary Artery Disease.
    Circulation. 2020 Jun 11. doi: 10.1161/CIRCULATIONAHA.119.044442.
    >> Share

  92. AL-KHATIB SM, Benjamin EJ, Albert CM, Alonso A, et al
    Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop.
    Circulation. 2020;141:1915-1926.
    >> Share

  93. PANDEY A, Vaduganathan M, Arora S, Qamar A, et al
    Temporal Trends in Prevalence & Prognostic Implications of Comorbidities Among Patients with Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047019.
    >> Share

  94. HONG YS, Longchamps RJ, Zhao D, Castellani CA, et al
    Mitochondrial DNA Copy Number and Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study.
    Circulation. 2020;141:1823-1825.
    >> Share

  95. SELVARAJ S, Kelly DP, Margulies KB
    Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Circulation. 2020;141:1800-1812.
    >> Share

  96. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    >> Share

    May 2020
  97. SARMA S, Levine BD
    Response by Sarma and Levine to Letter Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
    Circulation. 2020;141:e822.
    >> Share

  98. KOMAMURA K
    Letter by Komamura Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
    Circulation. 2020;141:e819.
    >> Share

  99. BELKIN M, Michou E, Mueller C
    Letter by Belkin et al Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
    Circulation. 2020;141:e820-e821.
    >> Share

  100. NWABUO CC, Rana JS
    Letter by Nwabuo and Rana Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
    Circulation. 2020;141:e817-e818.
    >> Share

  101. BELHADJER Z, Meot M, Bajolle F, Khraiche D, et al
    Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic.
    Circulation. 2020 May 17. doi: 10.1161/CIRCULATIONAHA.120.048360.
    >> Share

  102. GRIFFIN M, Rao VS, Ivey-Miranda J, Fleming J, et al
    Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects.
    Circulation. 2020 May 15. doi: 10.1161/CIRCULATIONAHA.120.045691.
    >> Share


  103. Correction to: Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations.
    Circulation. 2020;141:e809.
    >> Share

    April 2020
  104. BADOLIA R, Ramadurai DKA, Abel ED, Ferrin P, et al
    The Role of Non-Glycolytic Glucose Metabolism in Myocardial Recovery upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.
    Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.119.044452.
    >> Share

  105. KITKO L, McIlvennan CK, Bidwell JT, Dionne-Odom JN, et al
    Family Caregiving for Individuals With Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Apr 30:CIR0000000000000768. doi: 10.1161/CIR.0000000000000768.
    >> Share

  106. WHITE-WILLIAMS C, Rossi LP, Bittner VA, Driscoll A, et al
    Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Apr 30:CIR0000000000000767. doi: 10.1161/CIR.0000000000000767.
    >> Share

  107. ARMSTRONG PW
    Enhancing Cardiovascular Care: Global Collaboration Is How It Happens.
    Circulation. 2020;141:1357-1359.
    >> Share

  108. GIERULA J, Lowry JE, Paton MF, Cole CA, et al
    Personalised Rate-Response Programming Improves Exercise Tolerance After Six Months in People with Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
    Circulation. 2020 Apr 17. doi: 10.1161/CIRCULATIONAHA.119.045066.
    >> Share

  109. KARAM S, Margaria JP, Bourcier A, Mika D, et al
    Cardiac Overexpression of PDE4B Blunts beta-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Circulation. 2020 Apr 8. doi: 10.1161/CIRCULATIONAHA.119.042573.
    >> Share

  110. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    >> Share

  111. CHIRINOS JA, Zhao L, Jia Y, Frej C, et al
    Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure.
    Circulation. 2020 Apr 2. doi: 10.1161/CIRCULATIONAHA.119.045323.
    >> Share

    March 2020
  112. TOTO RD
    Leveraging the Peritoneum as a New Diuretic Strategy for Heart Failure.
    Circulation. 2020;141:1054-1056.
    >> Share

  113. SHAH SJ, Borlaug BA, Kitzman DW, McCulloch AD, et al
    Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.
    Circulation. 2020;141:1001-1026.
    >> Share

  114. LITTMANN L
    Letter by Littmann Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure R
    Circulation. 2020;141:e646-e647.
    >> Share

  115. SCHRAGE B, Linde C, Braunschweig F, Savarese G, et al
    Response by Schrage et al to Letter Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedis
    Circulation. 2020;141:e648-e649.
    >> Share

  116. CHARTON M, Flecher E, Leclercq C, Delmas C, et al
    Suicide Attempts Among LVAD Recipients: Real-Life Data From the ASSIST-ICD Study.
    Circulation. 2020;141:934-936.
    >> Share

  117. CAPORIZZO MA, Chen CY, Bedi K, Margulies KB, et al
    Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium.
    Circulation. 2020;141:902-915.
    >> Share

  118. PANDEY A, Patel KV, Bahnson JL, Gaussoin SA, et al
    Association of Intensive Lifestyle Intervention, Fitness and Body Mass Index with Risk of Heart Failure in Overweight or Obese Adults with Type 2 Diabetes Mellitus: An Analysis from the Look AHEAD Trial.
    Circulation. 2020 Mar 5. doi: 10.1161/CIRCULATIONAHA.119.044865.
    >> Share

  119. SCHIATTARELLA GG, Tong D, Hill JA
    Can HFpEF and HFrEF Coexist?
    Circulation. 2020;141:709-711.
    >> Share

    February 2020
  120. KUEHN BM
    Race May Influence Transplant Decision Making in Heart Failure: Studies Also Detail Disparities in Hypertension Diagnosis, Statin Prescribing.
    Circulation. 2020;141:694-695.
    >> Share

  121. ROSENKRANZ S, Howard LS, Gomberg-Maitland M, Hoeper MM, et al
    Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.
    Circulation. 2020;141:678-693.
    >> Share

  122. OMIYA S, Omori Y, Taneike M, Murakawa T, et al
    Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts.
    Circulation. 2020;141:667-677.
    >> Share

  123. HILFIKER-KLEINER D, Konig T, Bauersachs J
    Natriuretic Peptide Receptor 1, a Novel Player in Peripartum Heart Failure.
    Circulation. 2020;141:589-591.
    >> Share

  124. KHOSROW-KHAVAR F, Filion KB, Bouganim N, Suissa S, et al
    Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
    Circulation. 2020;141:549-559.
    >> Share

  125. KUEHN BM
    Biomarkers May Help Stratify Patient Heart Failure Risk, Guide Treatment.
    Circulation. 2020;141:399-400.
    >> Share

  126. BOZKURT B, Ezekowitz J
    Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials.
    Circulation. 2020;141:362-366.
    >> Share

    January 2020
  127. BERGMARK BA, Bhatt DL, McGuire DK, Scirica BM, et al
    Response by Bergmark et al to Letter Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial".
    Circulation. 2020;141:e57-e58.
    >> Share

  128. MORDI IR, Mohan M, Lang CC
    Letter by Mordi et al Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial".
    Circulation. 2020;141:e55-e56.
    >> Share

  129. GOMES CPDC, Schroen B, Kuster GM, Robinson EL, et al
    Regulatory RNAs in Heart Failure.
    Circulation. 2020;141:313-328.
    >> Share

  130. LEWIS AA, Ayers CR, Selvin E, Neeland I, et al
    Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multi-Cohort Study.
    Circulation. 2020 Jan 14. doi: 10.1161/CIRCULATIONAHA.119.043628.
    >> Share

  131. HIEDA M, Sarma S, Hearon CM Jr, Dias KA, et al
    Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.
    Circulation. 2020;141:115-123.
    >> Share

  132. PATERSON DI, Wells G, Erthal F, Mielniczuk L, et al
    OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients with Non-Ischemic Heart Failure (IMAGE-HF 1B).
    Circulation. 2020 Jan 8. doi: 10.1161/CIRCULATIONAHA.119.043964.
    >> Share

  133. PACKER M, Lam CSP, Lund LH, Redfield MM, et al
    Interdependence of Atrial Fibrillation and Heart Failure With a Preserved Ejection Fraction Reflects a Common Underlying Atrial and Ventricular Myopathy.
    Circulation. 2020;141:4-6.
    >> Share

  134. FAYSSOIL A
    Letter by Fayssoil Regarding Article, "Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction".
    Circulation. 2020;141:e1-e2.
    >> Share

    December 2019
  135. BUTLER J, Packer M, Greene SJ, Fiuzat M, et al
    Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
    Circulation. 2019;140:2108-2118.
    >> Share

    November 2019
  136. TONG D, Schiattarella GG, Jiang N, May HI, et al
    Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;140:1769-1771.
    >> Share

  137. SOLOMON SD, Vaduganathan M, Claggett BL, Packer M, et al
    Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044586.
    >> Share

  138. MCMURRAY JJV, Jackson AM, Lam CSP, Redfield MM, et al
    Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044491.
    >> Share

  139. KOSIBOROD MN, Jhund P, Docherty KF, Diez M, et al
    Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044138.
    >> Share

  140. FELKER GM
    Building the Foundation for a New Era of Quadruple Therapy in Heart Failure.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044578.
    >> Share

  141. MARTINEZ FA, Serenelli M, Nicolau JC, Petrie MC, et al
    Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044133.
    >> Share

  142. DEHARO P, Bisson A, Herbert J, Lacour T, et al
    Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis: Data from a Nationwide Analysis.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043971.
    >> Share

  143. ARNOTT C, Neal B
    Do GLP-1 Receptor Agonists Care if You Have Heart Failure?
    Circulation. 2019;140:1623-1625.
    >> Share

  144. JIA X, Sun W, Hoogeveen RC, Nambi V, et al
    Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
    Circulation. 2019;140:e772-e773.
    >> Share

  145. LI D, Cheng Y
    Letter by Li and Cheng Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
    Circulation. 2019;140:e770-e771.
    >> Share

  146. DJOUSSE L, Cook NR, Kim E, Bodar V, et al
    Supplementation with Vitamin D and/or Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044645.
    >> Share

    October 2019
  147. MARTINI E, Kunderfranco P, Peano C, Carullo P, et al
    Single Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation.
    Circulation. 2019 Oct 30. doi: 10.1161/CIRCULATIONAHA.119.041694.
    >> Share

  148. ELGHAZALY H, Hajiev S, Singh P
    Letter by Elghazaly et al Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus".
    Circulation. 2019;140:e738-e739.
    >> Share

  149. KATO ET, Sabatine MS, Wiviott SD
    Response by Kato et al to Letter Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus".
    Circulation. 2019;140:e740-e741.
    >> Share

  150. DRAZNER MH, Stevenson LW
    Relief and Prevention of Congestion in Heart Failure Enhance Quality and Length of Life.
    Circulation. 2019;140:1380-1382.
    >> Share

  151. TROMP J, Hage C, Ouwerkerk W, Sanders-van Wijk S, et al
    Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;140:1359-1361.
    >> Share

  152. KUEHN BM
    Gut Microbes Role in Heart Failure Explored.
    Circulation. 2019;140:1217-1218.
    >> Share

  153. TIAN R, Colucci WS, Arany Z, Bachschmid MM, et al
    Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure-A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
    Circulation. 2019;140:1205-1216.
    >> Share

    September 2019
  154. BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
    >> Share

  155. BONOW RO, Mark DB, O'Gara PT
    Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043408.
    >> Share

  156. AUNG N, Vargas JD, Yang C, Cabrera CP, et al
    Genome-Wide Analysis of Left Ventricular Image-Derived Phenotypes Identifies Fourteen Loci Associated with Cardiac Morphogenesis and Heart Failure Development.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.041161.
    >> Share

  157. FUDIM M, White J, Pagidipati NJ, Lokhnygina Y, et al
    Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
    Circulation. 2019 Sep 23. doi: 10.1161/CIRCULATIONAHA.119.041659.
    >> Share

  158. KHAZANIE P, Drazner MH
    The Blurred Line between Gaming and Patient Advocacy: Heart Transplant Listing Decisions in the Modern Era.
    Circulation. 2019 Sep 18. doi: 10.1161/CIRCULATIONAHA.119.043034.
    >> Share


  159. Correction to: Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
    Circulation. 2019;140:e692.
    >> Share

  160. NASSIF ME, Windsor S, Tang F, Khariton Y, et al
    Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
    Circulation. 2019 Sep 16. doi: 10.1161/CIRCULATIONAHA.119.042929.
    >> Share

  161. SELVARAJ S, Claggett B, Pozzi A, McMurray JJV, et al
    Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients with Heart Failure and Reduced Ejection Fraction:PARADIGM-HF.
    Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.039920.
    >> Share

  162. SCHRAGE B, Uijl A, Benson L, Westermann D, et al
    Association Between Use of Primary Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients with Heart Failure: A Prospective Propensity-Score Matched Analysis from the Swedish Heart Failure Registry.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043012.
    >> Share

  163. AL-KHATIB SM, Kusumoto FM
    Implantable Cardioverter Defibrillators Have Stood the Test of Time!
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043354.
    >> Share

    August 2019
  164. BERG DD, Wiviott SD, Scirica BM, Gurmu Y, et al
    Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
    Circulation. 2019 Aug 31. doi: 10.1161/CIRCULATIONAHA.119.042685.
    >> Share

  165. GRACIA E, Hamid A, Butler J
    Timely Management of New-Onset Heart Failure.
    Circulation. 2019;140:621-623.
    >> Share

  166. CLELAND JGF, Pellicori P
    Myocardial Dysfunction and Coronary Artery Disease as Therapeutic Targets in Heart Failure.
    Circulation. 2019;140:538-541.
    >> Share

  167. PACKER M
    Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
    Circulation. 2019;140:443-445.
    >> Share

    July 2019
  168. BERGMARK BA, Bhatt DL, McGuire DK, Cahn A, et al
    Metformin Use and Clinical Outcomes among Patients with Diabetes with or without Heart Failure or Kidney Dysfunction: Observations from the SAVOR-TIMI 53 Trial.
    Circulation. 2019 Jul 31. doi: 10.1161/CIRCULATIONAHA.119.040144.
    >> Share

  169. SENNI M, Caravita S, Paulus WJ
    Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction?
    Circulation. 2019;140:366-369.
    >> Share

  170. FAN Q, Mao H, Angelini A, Coarfa C, et al
    Depletion of Endothelial Prolyl Hydroxylase Domain Protein 2 and 3 Promotes Cardiomyocyte Proliferation and Prevents Ventricular Failure Induced by Myocardial Infarction.
    Circulation. 2019;140:440-442.
    >> Share

  171. FELDMAN AM, Gerhard GS, Cheung JY
    Letter by Feldman et al Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery".
    Circulation. 2019;140:e5-e6.
    >> Share

  172. ARAGAM KG, Chaffin M, Ellinor PT, Kathiresan S, et al
    Response by Aragam et al to Letter Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery".
    Circulation. 2019;140:e7-e8.
    >> Share

    June 2019
  173. VERMA S, Lam CSP, Kosiborod M
    Empagliflozin and Heart Failure.
    Circulation. 2019;139:2831-2834.
    >> Share

  174. KRONLAGE M, Dewenter M, Grosso J, Fleming T, et al
    O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart from Failure.
    Circulation. 2019 Jun 14. doi: 10.1161/CIRCULATIONAHA.117.031942.
    >> Share

  175. GOLDENBERG JR, Carley AN, Ji R, Zhang X, et al
    Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Circulation. 2019;139:2765-2777.
    >> Share

  176. DUNLAY SM, Givertz MM, Aguilar D, Allen LA, et al
    Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
    Circulation. 2019 Jun 6:CIR0000000000000691. doi: 10.1161/CIR.0000000000000691.
    >> Share

  177. BRANCH KR, Probstfield JL, Eikelboom JW, Bosch J, et al
    Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609.
    >> Share

    May 2019
  178. BENFARI G, Antoine C, Miller WL, Thapa P, et al
    Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038946.
    >> Share

  179. VAN DER MEER P, van der Wal HH, Melenovsky V
    Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart Failure.
    Circulation. 2019;139:2399-2402.
    >> Share

  180. TESTANI JM, Inzucchi SE, Voors AA
    Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time?
    Circulation. 2019;139:2383-2385.
    >> Share

  181. SEPEHRVAND N, Alemayehu W, Dyck GJB, Dyck JRB, et al
    External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.
    Circulation. 2019;139:2377-2379.
    >> Share

  182. NYSTROM T, Sartipy U, Contardi A, Lind M, et al
    Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction.
    Circulation. 2019;139:2380-2382.
    >> Share

  183. SMITH GL, Eisner DA
    Calcium Buffering in the Heart in Health and Disease.
    Circulation. 2019;139:2358-2371.
    >> Share

  184. ENRIQUEZ-SARANO M, Michelena HI, Grigioni F
    Treatment of Functional Mitral Regurgitation.
    Circulation. 2019;139:2289-2291.
    >> Share

  185. GOPINATHANNAIR R, Cornwell WK, Dukes JW, Ellis CR, et al
    Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.
    Circulation. 2019;139:e967-e989.
    >> Share

  186. PACKER M, Grayburn PA
    Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
    Circulation. 2019 May 1. doi: 10.1161/CIRCULATIONAHA.119.039612.
    >> Share

    April 2019
  187. JIA X, Sun W, Hoogeveen RC, Nambi V, et al
    High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
    Circulation. 2019 Apr 29. doi: 10.1161/CIRCULATIONAHA.118.038772.
    >> Share

  188. SANO M, Goto S
    Possible Mechanism of Hematocrit Elevation by Sodium Glucose Cotransporter 2 Inhibitors and Associated Beneficial Renal and Cardiovascular Effects.
    Circulation. 2019;139:1985-1987.
    >> Share

  189. RANGASWAMI J, Bhalla V, Blair JEA, Chang TI, et al
    Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
    Circulation. 2019;139:e840-e878.
    >> Share

  190. SEGAR MW, Patel KV, Berry JD, Grodin JL, et al
    Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;139:1851-1853.
    >> Share

  191. MORROW DA, Velazquez EJ, DeVore AD, Desai AS, et al
    Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.
    Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.039331.
    >> Share

  192. PATORNO E, Pawar A, Franklin JM, Najafzadeh M, et al
    Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care: A First Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.
    Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.039177.
    >> Share

    March 2019
  193. NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
    Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
    >> Share

  194. BOTS SH, den Ruijter HM
    Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
    Circulation. 2019;139:1469-1471.
    >> Share

  195. KATO ET, Silverman MG, Mosenzon O, Zelniker TA, et al
    Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040130.
    >> Share

  196. VERMA S, McMurray JJV
    The Serendipitous Story of SGLT2 Inhibitors in Heart Failure: New Insights from DECLARE-TIMI 58.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040514.
    >> Share

  197. FURTADO RHM, Bonaca MP, Raz I, Zelniker TA, et al
    Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039996.
    >> Share

  198. JUKEMA JW, Timal RJ, Rotmans JI, Hensen LCR, et al
    Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients: The Prospective Randomized Controlled ICD2 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039818.
    >> Share

  199. FIGTREE GA, Radholm K, Barrett TD, Perkovic V, et al
    Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040057.
    >> Share

  200. KUMAR AA, Kelly DP, Chirinos JA
    Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;139:1435-1450.
    >> Share

  201. SAVARESE G, Sattar N, Januzzi J, Verma S, et al
    Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.
    Circulation. 2019;139:1458-1460.
    >> Share

    February 2019
  202. SAHA P, Potiny P, Rigdon J, Morello M, et al
    Substantial Cardiovascular Morbidity in Adults with Lower-Complexity Congenital Heart Disease.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.037064.
    >> Share

  203. COLLINS SP, Pang PS
    ACUTE Heart Failure Risk Stratification.
    Circulation. 2019;139:1157-1161.
    >> Share

  204. RAWSHANI A, Rawshani A, Sattar N, Franzen S, et al
    Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes.
    Circulation. 2019 Feb 25. doi: 10.1161/CIRCULATIONAHA.118.037454.
    >> Share

  205. HSICH EM
    Sex Differences in Advanced Heart Failure Therapies.
    Circulation. 2019;139:1080-1093.
    >> Share

  206. CHARLES-EDWARDS G, Amaral N, Sleigh A, Ayis S, et al
    Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients with Chronic Heart Failure and Iron Deficiency: The FERRIC-HF II Randomized Mechanistic Trial.
    Circulation. 2019 Feb 19. doi: 10.1161/CIRCULATIONAHA.118.038516.
    >> Share

  207. DEL BUONO MG, Carbone S, Abbate A
    Letter by Del Buono et al Regarding Article, "A Simple, Evidence-Based Approach To Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2019;139:990-991.
    >> Share

  208. COBOS GIL MA
    Letter by Cobos Gil Regarding Article, "A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2019;139:989.
    >> Share

  209. REDDY YNV, Borlaug BA
    Response by Reddy and Borlaug to Letters Regarding Article, "A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2019;139:992-993.
    >> Share

  210. MORDI IR, Pearson ER, Palmer CNA, Doney ASF, et al
    Differential Association of Genetic Risk of Coronary Artery Disease With Development of Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Circulation. 2019;139:986-988.
    >> Share

  211. LEE DP, Tan WLW, Anene-Nzelu CG, Lee CJM, et al
    A Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene Response.
    Circulation. 2019 Feb 5. doi: 10.1161/CIRCULATIONAHA.118.036726.
    >> Share

    January 2019
  212. CHEN Y, Nilsson J, Liang C
    Letter by Chen et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
    Circulation. 2019;139:716-717.
    >> Share

  213. MEIJERS WC, de Boer RA
    Response by Meijers and de Boer to Letters Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
    Circulation. 2019;139:720-721.
    >> Share

  214. DEVORE AD, Bhatt AS
    Influenza Vaccination in Patients With Heart Failure.
    Circulation. 2019;139:587-589.
    >> Share

  215. ZHANG J, Lan HY, Wan S
    Letter by Zhang et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
    Circulation. 2019;139:718-719.
    >> Share

  216. MATHIYALAGAN P, Adamiak M, Mayourian J, Sassi Y, et al
    FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.
    Circulation. 2019;139:518-532.
    >> Share

  217. FIGTREE GA, Radholm K, Neal B
    Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:418-419.
    >> Share

  218. KOH KK
    Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:416-417.
    >> Share

  219. ZANNAD F, Rossignol P
    Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure.
    Circulation. 2019;139:362-365.
    >> Share

  220. ZHOU L, Li Z, Wang DW
    Response by Zhou et al to Letter Regarding Article, "Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure".
    Circulation. 2019;139:301-302.
    >> Share

  221. GREENE SJ, Butler J
    Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.
    Circulation. 2019;139:152-154.
    >> Share

  222. FRANGOGIANNIS NG
    Protean Functions and Phenotypic Plasticity of Regulatory T Cells in Chronic Ischemic Heart Failure.
    Circulation. 2019;139:222-225.
    >> Share

  223. MORIS D, Karachaliou GS, Karaolanis G
    Letter by Moris et al Regarding Article, "Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure".
    Circulation. 2019;139:299-300.
    >> Share

  224. ANDERSEN S, Nielsen-Kudsk JE, Vonk Noordegraaf A, de Man FS, et al
    Right Ventricular Fibrosis.
    Circulation. 2019;139:269-285.
    >> Share

    December 2018
  225. ANAND I, Gupta P
    Response by Anand and Gupta to Letter Regarding Article, "Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies".
    Circulation. 2018;138:2976-2977.
    >> Share

  226. DE LAS NIEVES LOPEZ MA
    Letter by de las Nieves Lopez Regarding Article, "Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies".
    Circulation. 2018;138:2974-2975.
    >> Share

  227. TROMP J, MacDonald MR, Tay WT, Teng TK, et al
    Heart Failure With Preserved Ejection Fraction in the Young.
    Circulation. 2018;138:2763-2773.
    >> Share

  228. AMBROSY AP, Parzynski CS, Friedman DJ, Fudim M, et al
    Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
    Circulation. 2018;138:2787-2797.
    >> Share

  229. JERNBERG T, Lindahl B, Alfredsson J, Berglund E, et al
    Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
    Circulation. 2018;138:2754-2762.
    >> Share

  230. MODIN D, Jorgensen ME, Gislason G, Jensen JS, et al
    Influenza Vaccine in Heart Failure: Cumulative Number of Vaccinations, Frequency, Timing, and Survival: A Danish Nationwide Cohort Study.
    Circulation. 2018 Dec 10. doi: 10.1161/CIRCULATIONAHA.118.036788.
    >> Share

  231. FITCHETT D, Inzucchi SE, Cannon CP, McGuire DK, et al
    Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
    Circulation. 2018 Dec 6. doi: 10.1161/CIRCULATIONAHA.118.037778.
    >> Share

  232. KANG DH, Park SJ, Shin SH, Hong GR, et al
    Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.037077.
    >> Share

  233. DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
    Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
    Circulation. 2018;138:2597-2607.
    >> Share

    November 2018
  234. LEE DS, Lee JS, Schull MJ, Borgundvaag B, et al
    Prospective Validation of the Emergency Heart Failure Mortality Risk Grad for Acute Heart Failure: The Acute Congestive Heart Failure Urgent Care Evaluation (ACUTE) Study.
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.035509.
    >> Share

  235. SHAH R, Latham SB
    Letter by Shah and Latham Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With the Guidelines-Heart Failure".
    Circulation. 2018;138:2303-2304.
    >> Share

  236. REISMAN L
    Letter by Reisman Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
    Circulation. 2018;138:2301-2302.
    >> Share

  237. MAHLA RS
    Letter by Mahla Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
    Circulation. 2018;138:2305.
    >> Share

  238. KUMBHANI DJ, Fonarow GC, Heidenreich PA, Schulte PJ, et al
    Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
    Circulation. 2018;138:2306-2307.
    >> Share

  239. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth Universal Definition of Myocardial Infarction (2018).
    Circulation. 2018;138:e618-e651.
    >> Share

  240. EVERETT BM, Cornel J, Lainscak M, Anker SD, et al
    Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038010.
    >> Share

  241. MCGUIRE DK, Alexander JH, Johansen OE, Perkovic V, et al
    Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038352.
    >> Share

  242. ARAGAM KG, Chaffin M, Levinson RT, McDermott G, et al
    Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035774.
    >> Share

    October 2018
  243. MATSUMOTO J, Takada S, Kinugawa S, Furihata T, et al
    Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.
    Circulation. 2018;138:2064-2066.
    >> Share

  244. LEROY J, Fischmeister R
    Inhibit a Phosphodiesterase to Treat Heart Failure?
    Circulation. 2018;138:2003-2006.
    >> Share

  245. KOK W, Stienen S
    Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Adm
    Circulation. 2018;138:1910-1911.
    >> Share

  246. MADIAS JE
    Letter by Madias Regarding Article, "NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Deco
    Circulation. 2018;138:1908-1909.
    >> Share

  247. MONTERO D
    Letter by Montero Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
    Circulation. 2018;138:1757-1758.
    >> Share

  248. CALVERLEY TA, Bailey DM
    Letter by Calverley and Bailey Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
    Circulation. 2018;138:1755-1756.
    >> Share

  249. HOWDEN EJ, Levine BD
    Response by Howden and Levine to Letters Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
    Circulation. 2018;138:1759-1760.
    >> Share

  250. ALOIA E
    Letter by Aloia Regarding Article, "Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality".
    Circulation. 2018;138:1612.
    >> Share

  251. NUNEZ J, Nunez E, Sanchis J, Bayes-Genis A, et al
    Response by Nunez et al to Letter Regarding Article, "Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality".
    Circulation. 2018;138:1613-1614.
    >> Share

    September 2018
  252. DAWSON J
    Pioglitazone Use After Stroke.
    Circulation. 2018;138:1221-1223.
    >> Share

  253. COLOMBO PC, Mehra MR, Goldstein DJ, Estep JD, et al
    Comprehensive Analysis of Stroke in the LongTerm Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump.
    Circulation. 2018 Sep 17. doi: 10.1161/CIRCULATIONAHA.118.037231.
    >> Share

  254. GREENE SJ, Mentz RJ, Fiuzat M, Butler J, et al
    Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure.
    Circulation. 2018;138:1039-1053.
    >> Share

    August 2018
  255. BERTERO E, Canepa M, Maack C, Ameri P, et al
    Linking Heart Failure to Cancer.
    Circulation. 2018;138:735-742.
    >> Share

  256. ALOIA E
    Letter by Aloia Regarding Article, "Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Su
    Circulation. 2018;138:656-657.
    >> Share

  257. SOLIMAN O, Akin S, Muslem R, Caliskan K, et al
    Response by Soliman et al to Letter Regarding Article, "Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients With Mecha
    Circulation. 2018;138:658-659.
    >> Share

  258. SARRIAS A, Bayes-Genis A
    Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
    Circulation. 2018;138:551-553.
    >> Share

    July 2018
  259. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    >> Share

  260. ANAND IS, Gupta P
    Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies.
    Circulation. 2018;138:80-98.
    >> Share

  261. ROGER VL
    Heart Failure Epidemic: It's Complicated....
    Circulation. 2018;138:25-28.
    >> Share

  262. SATTAR N, McGuire DK
    Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.
    Circulation. 2018;138:7-9.
    >> Share

    June 2018
  263. MCALLISTER DA, Read S, Kerssens J, Livingstone S, et al
    Incidence of Hospitalisation for Heart Failure and Case-Fatality Among 3.25 Million People with and without Diabetes.
    Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.034986.
    >> Share

  264. YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
    Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
    Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
    >> Share


  265. Correction to: Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
    Circulation. 2018;137:e853.
    >> Share

  266. SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
    The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
    >> Share

    May 2018
  267. PACKER M, Kowey PR
    Building Castles in the Sky: Catheter Ablation in Patients With Atrial Fibrillation and Chronic Heart Failure.
    Circulation. 2018 May 30. pii: CIRCULATIONAHA.118.034583.
    >> Share

  268. MEHRA MR, Salerno C, Cleveland JC, Pinney S, et al
    Health Care Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: A Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure.
    Circulation. 2018 May 27. pii: CIRCULATIONAHA.118.035722.
    >> Share

  269. FUDIM M, Jones WS, Boortz-Marx RL, Ganesh A, et al
    Splanchnic Nerve Block for Acute Heart Failure.
    Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.035260.
    >> Share

  270. REDDY YNV, Carter RE, Obokata M, Redfield MM, et al
    A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646.
    >> Share

  271. WALKER MA, Tian R
    Raising NAD in Heart Failure: Time to Translate?
    Circulation. 2018;137:2274-2277.
    >> Share

  272. ELMING MB, Signorovitch J, Kober L, Thune JJ, et al
    Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2190.
    >> Share

  273. ADABAG S, Wininger M, Singh SN
    Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2188-2189.
    >> Share

  274. JANUZZI JL JR, Richards AM
    Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study.
    Circulation. 2018;137:2101-2103.
    >> Share

  275. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".
    Circulation. 2018;137:1984-1985.
    >> Share

  276. GROCOTT HP
    Letter by Grocott Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".
    Circulation. 2018;137:1983.
    >> Share

  277. PACKER M
    Response by Packer to Letter Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchange Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
    Circulation. 2018;137:1981-1982.
    >> Share

  278. GAZMURI RJ, Karmazyn M
    Letter by Gazmuri and Karmazyn Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
    Circulation. 2018;137:1979-1980.
    >> Share

    April 2018
  279. LEOPOLD JA
    Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
    Circulation. 2018;137:1811-1813.
    >> Share

  280. CHIANG DY, Alsina KM, Corradini E, Fitzpatrick M, et al
    Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.
    Circulation. 2018 Apr 18. pii: CIRCULATIONAHA.118.034361.
    >> Share

  281. KAMIMURA D, Cain LR, Mentz RJ, White WB, et al
    Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.
    Circulation. 2018 Apr 16. pii: CIRCULATIONAHA.117.031912.
    >> Share

  282. CHEN LY, Chung MK, Allen LA, Ezekowitz M, et al
    Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 16. pii: CIR.0000000000000568.
    >> Share

  283. VALIENTE-ALANDI I, Potter SJ, Salvador AM, Schafer AE, et al
    Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Circulation. 2018 Apr 13. pii: CIRCULATIONAHA.118.034609.
    >> Share

  284. KONSTAM MA, Kiernan MS, Bernstein D, Bozkurt B, et al
    Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 12. pii: CIR.0000000000000560.
    >> Share

  285. PACKER M
    Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity.
    Circulation. 2018;137:1614-1631.
    >> Share

    March 2018
  286. KUSHNIR A, Santulli G, Reiken SR, Coromilas E, et al
    Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.117.032703.
    >> Share

  287. SWEITZER NK, Airhart S
    New Therapeutic Target in Heart Failure: Achieving and Maintaining Normokalemia.
    Circulation. 2018;137:1331-1333.
    >> Share

  288. ANDERSSON C, Lyass A, Lin H, Kober L, et al
    Association of Genetic Variation in Coronary Artery Disease-Related Loci With the Risk of Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Circulation. 2018;137:1290-1292.
    >> Share

  289. AUBDOOL AA, Argunhan F, Thakore P, Brain SD, et al
    Response by Aubdool et al to Letters Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1201-1202.
    >> Share

  290. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1200.
    >> Share

  291. TSUDA K
    Letter by Tsuda Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1198-1199.
    >> Share

  292. RADHOLM K, Figtree G, Perkovic V, Solomon SD, et al
    Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.034222.
    >> Share

  293. CHANG PP, Wruck LM, Shahar E, Rossi JS, et al
    Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.
    Circulation. 2018 Mar 8. pii: CIRCULATIONAHA.117.027551.
    >> Share

  294. VIJAYAKUMAR S, Vaduganathan M, Butler J
    Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.
    Circulation. 2018;137:1060-1073.
    >> Share

    February 2018
  295. MORINE KJ, Qiao X, York S, Natov PS, et al
    Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
    Circulation. 2018 Feb 27. pii: CIRCULATIONAHA.117.031635.
    >> Share

  296. KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
    Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of C
    Circulation. 2018;137:989-991.
    >> Share

  297. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovas
    Circulation. 2018;137:988.
    >> Share

  298. TAEGTMEYER H, Karlstaedt A
    Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Card
    Circulation. 2018;137:986-987.
    >> Share

  299. KOH KK
    Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in
    Circulation. 2018;137:984-985.
    >> Share

  300. TAMPAKI EC, Tampakis A, Pantos C
    Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular O
    Circulation. 2018;137:982-983.
    >> Share

  301. PINA IL, Zheng Q, She L, Szwed H, et al
    Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
    Circulation. 2018;137:771-780.
    >> Share

  302. WENGER NK
    Sauce for the Goose Versus Sauce for the Gander: Should Men and Women Play the Same Game But With Different Rules?
    Circulation. 2018;137:791-793.
    >> Share

  303. ZHOU L, Miao K, Yin B, Li H, et al
    The Cardioprotective Role of Myeloid-derived Suppressor Cells in Heart Failure.
    Circulation. 2018 Feb 1. pii: CIRCULATIONAHA.117.030811.
    >> Share

    January 2018
  304. FLORIDO R, Kwak L, Lazo M, Nambi V, et al
    Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study.
    Circulation. 2018 Jan 31. pii: CIRCULATIONAHA.117.030226.
    >> Share

  305. REDDY YNV, Obokata M, Gersh BJ, Borlaug BA, et al
    High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.
    Circulation. 2018;137:534-535.
    >> Share

  306. KUMBHANI DJ, Fonarow GC, Heidenreich PA, Schulte PJ, et al
    Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure.
    Circulation. 2018 Jan 29. pii: CIRCULATIONAHA.117.028077.
    >> Share

  307. OBOKATA M, Borlaug BA
    Response by Obokata and Borlaug to Letters Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:416-417.
    >> Share

  308. CARBONE S, Canada JM, Abbate A
    Letter by Carbone et al Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:414-415.
    >> Share

  309. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:413.
    >> Share

  310. KOUTSAMPASOPOULOS K, Ouzouni C, Vogiatzis I
    Letter by Koutsampasopoulos et al Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:411-412.
    >> Share

  311. PANDEY A, Omar W, Ayers C, LaMonte M, et al
    Sex and Race Differences in Lifetime Risk of Heart Failure with Preserved Ejection Fraction and Heart Failure with Reduced Ejection Fraction.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.031622.
    >> Share

  312. AHMAD T, Jackson K, Rao VS, Tang WHW, et al
    Worsening Renal Function in Acute Heart Failure Patients Undergoing Aggressive Diuresis is Not Associated with Tubular Injury.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.030112.
    >> Share

  313. AIMO A, Januzzi JL Jr, Vergaro G, Ripoli A, et al
    Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
    Circulation. 2018;137:286-297.
    >> Share

  314. BORLAUG BA
    Can Oxygen Transport Analysis Tell Us Why People With Heart Failure With Preserved Ejection Fraction Feel So Poorly?
    Circulation. 2018;137:162-165.
    >> Share

  315. JOLLY SS, Gao P, Cairns JA, Yusuf S, et al
    Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).
    Circulation. 2018;137:206-209.
    >> Share

  316. NAMBI V, Deswal A, Ballantyne CM
    Prevention of "Failure": Is It a Failure of Prevention?
    Circulation. 2018;137:106-108.
    >> Share

  317. HOUSTIS NE, Eisman AS, Pappagianopoulos PP, Wooster L, et al
    Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis.
    Circulation. 2018;137:148-161.
    >> Share

  318. HOWDEN EJ, Sarma S, Lawley JS, Opondo M, et al
    Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications For Heart Failure Prevention.
    Circulation. 2018 Jan 8. pii: CIRCULATIONAHA.117.030617.
    >> Share

  319. GERSTEIN HC, Jung H, Ryden L, Diaz R, et al
    Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention).
    Circulation. 2018;137:88-90.
    >> Share

  320. STEHLIK J, Kobashigawa J, Hunt SA, Reichenspurner H, et al
    Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-of-the-Art Review.
    Circulation. 2018;137:71-87.
    >> Share

  321. CHUGH SS
    Disrupting the Approach to Sudden Cardiac Death: From Vulnerable Ejection Fraction to Vulnerable Patient.
    Circulation. 2018;137:7-9.
    >> Share

    December 2017
  322. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    >> Share

  323. STIENEN S, Salah K, Moons AH, Bakx AL, et al
    NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial.
    Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.029882.
    >> Share

  324. WU S, Lu Q, Wang Q, Ding Y, et al
    Binding of FUN14 Domain Containing 1 With Inositol 1,4,5-Trisphosphate Receptor in Mitochondria-Associated Endoplasmic Reticulum Membranes Maintains Mitochondrial Dynamics and Function in Hearts in Vivo.
    Circulation. 2017;136:2248-2266.
    >> Share

    November 2017
  325. DU J, Ma XL, Li Y, Chen B, et al
    Response by Du et al to Letter Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling".
    Circulation. 2017;136:2094-2095.
    >> Share

  326. LI Y, Liu B, Liang C
    Letter by Li et al Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling".
    Circulation. 2017;136:2092-2093.
    >> Share

  327. FELDMAN T, Mauri L, Kahwash R, Litwin S, et al
    A Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): A Phase 2, Randomized, Sham-Controlled Trial.
    Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.117.032094.
    >> Share

  328. UDELL JA, Yuan Z, Rush T, Sicignano NM, et al
    Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Co-Transporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.031227.
    >> Share


  329. Correction to: Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e345.
    >> Share

  330. MEHRA MR, Sundareswaran KS, Uriel N
    Response by Mehra et al to Letter Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure".
    Circulation. 2017;136:1872-1873.
    >> Share

  331. MALTAIS S, Tchantchaleishvili V, Stulak JM
    Letter by Maltais et al Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure".
    Circulation. 2017;136:1870-1871.
    >> Share

  332. AL-KHATIB SM, Pokorney SD
    Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?
    Circulation. 2017;136:1781-1783.
    >> Share

    October 2017
  333. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    >> Share

  334. MANN DL
    High-Resolution Chromatin Mapping in Heart Failure: Some Answers, but More Questions.
    Circulation. 2017;136:1626-1628.
    >> Share

  335. WOLSK E, Claggett B, Diaz R, Dickstein K, et al
    Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Circulation. 2017;136:1560-1562.
    >> Share

  336. PACKER M
    Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure.
    Circulation. 2017;136:1548-1559.
    >> Share

  337. RAU CD, Vondriska TM
    DNA Methylation and Human Heart Failure: Mechanisms or Prognostics.
    Circulation. 2017;136:1545-1547.
    >> Share

  338. BUTLER J, Anker SD
    The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?
    Circulation. 2017;136:1459-1461.
    >> Share

  339. NUNEZ J, Bayes-Genis A, Zannad F, Rossignol P, et al
    Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.030576.
    >> Share

  340. KATZ SD
    "Pumping Iron" to Improve Exercise Performance in Heart Failure: New Data and New Guidelines.
    Circulation. 2017;136:1384-1386.
    >> Share

  341. CHO JH, Zhang R, Kilfoil PJ, Gallet R, et al
    Delayed Repolarization Underlies Ventricular Arrhythmias in Rats with Heart Failure and Preserved Ejection Fraction.
    Circulation. 2017 Oct 3. pii: CIRCULATIONAHA.117.028202.
    >> Share

    September 2017
  342. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
    Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
    >> Share

  343. PANDEY A, Berry JD
    Physical Activity in Heart Failure With Preserved Ejection Fraction: Moving Toward a Newer Treatment Paradigm.
    Circulation. 2017;136:993-995.
    >> Share

  344. ELMING MB, Nielsen JC, Haarbo J, Videbaek L, et al
    Age and Outcomes of Primary Prevention Implantable Cardioverter Defibrillators in Patients with Non-Ischemic Systolic Heart Failure.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.028829.
    >> Share

  345. WAAGSTEIN F, Rutherford JD
    The Evolution of the Use of beta-Blockers to Treat Heart Failure: A Conversation With Finn Waagstein, MD.
    Circulation. 2017;136:889-893.
    >> Share

    August 2017
  346. CHRISTIANSEN MN, Kober L, Andersson C
    Response by Christiansen et al to Letters Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
    Circulation. 2017;136:886-887.
    >> Share

  347. KAUL P, Ezekowitz JA, McAlister FA
    Letter by Kaul et al Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
    Circulation. 2017;136:884-885.
    >> Share

  348. GABET A, Juilliere Y, Olie V
    Letter by Gabet et al Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
    Circulation. 2017;136:883.
    >> Share

  349. SOLIMAN OI, Akin S, Muslem R, Boersma E, et al
    Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices:The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030543.
    >> Share

  350. MEDER B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, et al
    Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and A Novel Class of Biomarkers for Heart Failure.
    Circulation. 2017 Aug 24. pii: CIRCULATIONAHA.117.027355.
    >> Share

  351. CHANG LL, DeVore AD, Granger BB, Eapen ZJ, et al
    Leveraging Behavioral Economics to Improve Heart Failure Care and Outcomes.
    Circulation. 2017;136:765-772.
    >> Share

  352. ROSA-GARRIDO M, Chapski DJ, Schmitt AD, Kimball TH, et al
    High Resolution Mapping of Chromatin Conformation in Cardiac Myocytes Reveals Structural Remodeling of the Epigenome in Heart Failure.
    Circulation. 2017 Aug 11. pii: CIRCULATIONAHA.117.029430.
    >> Share

  353. ELLINGSEN O, Halle M, Prescott E, Linke A, et al
    Response by Ellingsen et al to Letters Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:611-612.
    >> Share

  354. BIANCHI VE
    Letter by Bianchi Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:609-610.
    >> Share

  355. WISLOFF U, Lavie CJ, Rognmo O
    Letter by Wisloff et al Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:607-608.
    >> Share

  356. IELLAMO F, Volterrani M
    Letter by Iellamo and Volterrani Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:605-606.
    >> Share

  357. KUEHN BM
    How Low Is Too Low With Salt in Heart Failure? Randomized Studies Needed to Resolve Concern.
    Circulation. 2017;136:597-598.
    >> Share

  358. KALMAN JM, Sanders P, Rosso R, Calkins H, et al
    Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Circulation. 2017;136:490-499.
    >> Share

    July 2017
  359. OBOKATA M, Borlaug BA
    Response by Obokata and Borlaug to Letter Regarding Article, "Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study".
    Circulation. 2017;136:430-431.
    >> Share

  360. SMISETH OA, Nagueh SF
    Letter by Smiseth and Nagueh et al Regarding Article, "Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study".
    Circulation. 2017;136:428-429.
    >> Share

  361. MCALISTER FA, Youngson E, Kaul P
    Health Resource Implications of Heart Failure Hospitalizations in Younger Patients Compared With Older Patients.
    Circulation. 2017;136:424-427.
    >> Share

  362. KAPUR NK, Esposito ML, Bader Y, Morine KJ, et al
    Mechanical Circulatory Support Devices for Acute Right Ventricular Failure.
    Circulation. 2017;136:314-326.
    >> Share

  363. VAN VELDHUISEN DJ, Ponikowski P, van der Meer P, Metra M, et al
    Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency.
    Circulation. 2017 Jul 12. pii: CIRCULATIONAHA.117.027497.
    >> Share

  364. GILSTRAP LG, DeFilippis EM, Stevenson LW
    An Unintended Consequence of the 21st-Century Cures Act for Patients With Heart Failure.
    Circulation. 2017;136:123-125.
    >> Share

  365. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    >> Share

  366. KITZMAN DW, Lam CSP
    Obese Heart Failure With Preserved Ejection Fraction Phenotype: From Pariah to Central Player.
    Circulation. 2017;136:20-23.
    >> Share

    June 2017
  367. HEGDE S, Claggett B, Shah AM, Lewis EF, et al
    Physical Activity and Prognosis in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
    Circulation. 2017 Jun 21. pii: CIRCULATIONAHA.117.028002.
    >> Share

  368. RUBIN GA, Grinspan LT, Ginns J
    Of a Tortuous Nature: An Unusual Cause of Peripartum Congestive Heart Failure.
    Circulation. 2017;135:2567-2571.
    >> Share

  369. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    >> Share

    May 2017
  370. PARIKH KS, Lippmann SJ, Greiner M, Heidenreich PA, et al
    Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).
    Circulation. 2017;135:2077-2080.
    >> Share

  371. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    >> Share

  372. KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
    Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study.
    Circulation. 2017 May 18. pii: CIRCULATIONAHA.117.029190.
    >> Share

    April 2017
  373. YANCY CW, Jessup M, Bozkurt B, Butler J, et al
    2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of
    Circulation. 2017 Apr 28. pii: CIR.0000000000000509.
    >> Share

  374. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    >> Share

  375. CHOW SL, Maisel AS, Anand I, Bozkurt B, et al
    Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Apr 26. pii: CIR.0000000000000490.
    >> Share

  376. BRESS AP, Kramer H, Khatib R, Beddhu S, et al
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
    Circulation. 2017;135:1617-1628.
    >> Share

  377. VERMA A, Kalman JM, Callans DJ
    Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
    Circulation. 2017;135:1547-1563.
    >> Share

  378. GORTER TM, Rienstra M, van Veldhuisen DJ
    Measuring Pulmonary Artery Pressures in Heart Failure: A New Useful Diagnostic Tool?
    Circulation. 2017;135:1518-1521.
    >> Share

  379. GORI M, Senni M, Metra M
    High-Sensitive Cardiac Troponin for Prediction of Clinical Heart Failure: Are We Ready for Prime Time?
    Circulation. 2017;135:1506-1508.
    >> Share

  380. PACKER M
    Response by Packer to Letter Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective".
    Circulation. 2017;135:e892-e893.
    >> Share

  381. BROWN PM, Ezekowitz JA
    Letter by Brown and Ezekowitz Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective".
    Circulation. 2017;135:e889-e891.
    >> Share

  382. URIEL N, Colombo PC, Cleveland JC, Long JW, et al
    Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Circulation. 2017 Apr 6. pii: CIRCULATIONAHA.117.028303.
    >> Share

  383. OBOKATA M, Reddy YN, Pislaru SV, Melenovsky V, et al
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2017 Apr 5. pii: CIRCULATIONAHA.116.026807.
    >> Share

  384. LAM CS, Solomon SD
    Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction.
    Circulation. 2017;135:1279-1280.
    >> Share

    March 2017
  385. ROSAMOND WD, Johnson A
    Trends in Heart Failure Incidence in the Community: A Gathering Storm.
    Circulation. 2017;135:1224-1226.
    >> Share

  386. METHAWASIN M, Granzier H
    Response by Methawasin and Granzier to Letter Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection F
    Circulation. 2017;135:e681-e682.
    >> Share

  387. LEWIS GA, Miller CA
    Letter by Lewis and Miller Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2017;135:e679-e680.
    >> Share

  388. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    >> Share

  389. FIDLER MM, Reulen RC, Henson K, Kelly J, et al
    Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.
    Circulation. 2017;135:951-963.
    >> Share

  390. SUNDSTROM J, Bruze G, Ottosson J, Marcus C, et al
    Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.
    Circulation. 2017 Mar 3. pii: CIRCULATIONAHA.116.025629.
    >> Share

  391. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    >> Share

    February 2017
  392. KONSTAM MA, Abboud FM
    Ejection Fraction: Misunderstood and Overrated (Changing the Paradigm in Categorizing Heart Failure).
    Circulation. 2017;135:717-719.
    >> Share

  393. CHRISTIANSEN MN, Kober L, Weeke P, Vasan RS, et al
    Age-specific Trends in Incidence, Mortality and Comorbidities of Heart Failure in Denmark 1995-2012.
    Circulation. 2017 Feb 7. pii: CIRCULATIONAHA.116.025941.
    >> Share

  394. TIBURCY M, Hudson JE, Balfanz P, Schlick SF, et al
    Defined Engineered Human Myocardium with Advanced Maturation for Applications in Heart Failure Modelling and Repair.
    Circulation. 2017 Feb 6. pii: CIRCULATIONAHA.116.024145.
    >> Share

  395. SELIGER SL, Hong SN, Christenson RH, Kronmal R, et al
    High Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.116.025505.
    >> Share

  396. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    >> Share

    January 2017
  397. SAIKI H, Petersen IA, Scott CG, Bailey KR, et al
    Risk of Heart Failure with Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer.
    Circulation. 2017 Jan 29. pii: CIRCULATIONAHA.116.025434.
    >> Share

  398. PENG D, Zhang Y, Rosenthal DN, Palmon M, et al
    Impact of Heart Transplantation on the Functional Status of U.S. Children with End-Stage Heart Failure. Analysis of Data from the Organ Procurement and Transplantation Network.
    Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.115.016520.
    >> Share

  399. ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
    Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
    Circulation. 2017;135:400-402.
    >> Share

  400. NARAYAN HK, Finkelman BS, French B, Plappert T, et al
    Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations with Ejection Fraction Decline, Recovery, and Heart Failure Symptoms over 3 Years of Followup.
    Circulation. 2017 Jan 19. pii: CIRCULATIONAHA.116.023463.
    >> Share

  401. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failur
    Circulation. 2017;135:e22-e23.
    >> Share

  402. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Pr
    Circulation. 2017;135:e20-e21.
    >> Share

  403. ELLINGSEN O, Halle M, Conraads VM, Stoylen A, et al
    High Intensity Interval Training in Heart Failure Patients with Reduced Ejection Fraction.
    Circulation. 2017 Jan 12. pii: CIRCULATIONAHA.116.022924.
    >> Share

  404. SEIDEL T, Navankasattusas S, Ahmad AA, Diakos NA, et al
    Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading.
    Circulation. 2017 Jan 10. pii: CIRCULATIONAHA.116.024470.
    >> Share

  405. KRISTENSEN SL, Mogensen UM, Jhund PS, Petrie MC, et al
    Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Tria
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.024593.
    >> Share

    December 2016
  406. OBOKATA M, Kane GC, Reddy YN, Olson TP, et al
    The Role of Diastolic Stress Testing in the Evaluation for HFpEF:A Simultaneous Invasive-Echocardiographic Study.
    Circulation. 2016 Dec 30. pii: CIRCULATIONAHA.116.024822.
    >> Share

  407. JOLLY SS, James SK, Dzavik V, Cairns JA, et al
    Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
    Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
    >> Share

  408. MARQUES FZ, Nelson EM, Chu PY, Horlock D, et al
    High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.024545.
    >> Share

  409. ABU-TAHA IH, Heijman J, Hippe HJ, Wolf NM, et al
    Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.022852.
    >> Share

    November 2016
  410. NADRUZ W JR, Claggett BL, McMurray JJ, Packer M, et al
    Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Pros
    Circulation. 2016;134:1785-1787.
    >> Share

  411. SHAH AM, Claggett B, Loehr LR, Chang PP, et al
    Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.023361.
    >> Share

  412. MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
    Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
    >> Share

  413. PACKER M
    Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective.
    Circulation. 2016;134:1664-1678.
    >> Share

  414. GAGGIN HK, Liu Y, Lyass A, van Kimmenade RR, et al
    Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.023052.
    >> Share

  415. MEHRA MR, Lindenfeld J
    Highlights of the Annual Scientific Meeting of the Heart Failure Society of America 2016.
    Circulation. 2016;134:1505-1506.
    >> Share

  416. ZUHLKE L, Karthikeyan G, Engel ME, Rangarajan S, et al
    Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
    Circulation. 2016;134:1456-1466.
    >> Share

  417. LYNGBAKKEN MN, Skranes JB, de Lemos JA, Nygard S, et al
    Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023726.
    >> Share

  418. WANG Q, Liu Y, Fu Q, Xu B, et al
    Inhibiting Insulin-Mediated beta2AR Activation Prevents Diabetes-Associated Cardiac Dysfunction.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.022281.
    >> Share

  419. MCKELLAR SH, Fang JC
    An Age-Old Question: What Is Too Old for Coronary Artery Bypass Grafting in Heart Failure?
    Circulation. 2016;134:1325-1327.
    >> Share

  420. AL-KHATIB SM, Friedman P, Ellenbogen KA
    Defibrillators: Selecting the Right Device for the Right Patient.
    Circulation. 2016;134:1390-1404.
    >> Share

    October 2016
  421. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    >> Share

  422. FILIPPOV AA, Del Nido PJ, Vasilyev NV
    Management of Systemic Right Ventricular Failure in Patients With Congenitally Corrected Transposition of the Great Arteries.
    Circulation. 2016;134:1293-1302.
    >> Share

  423. FRIEDMAN DJ, Bao H, Spatz ES, Curtis JP, et al
    Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report from the National Cardiovascular Data Registry.
    Circulation. 2016 Oct 19. pii: CIRCULATIONAHA.116.022913.
    >> Share

  424. LEWINTER MM, Zile MR
    Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?
    Circulation. 2016;134:1100-1104.
    >> Share

  425. METHAWASIN M, Strom JG, Slater RE, Fernandez V, et al
    Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2016;134:1085-1099.
    >> Share


  426. Correction to: Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?
    Circulation. 2016;134:e307.
    >> Share

  427. COWIE MR
    Returning to Work: A Forgotten Aspect of Rehabilitation for Heart Failure.
    Circulation. 2016;134:1010-1012.
    >> Share

    September 2016

  428. Correction to: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart As
    Circulation. 2016;134:e298.
    >> Share

  429. MELGARI D, Ng GA, Hancox JC
    Letter by Melgari et al Regarding Article, "Ivabradine: Role in the Chronic Heart Failure Armamentarium".
    Circulation. 2016;134:e296-7.
    >> Share

  430. CALVERT PA, Northridge DB, Malik IS, Shapiro L, et al
    Percutaneous Device Closure of Paravalvular Leak: Combined Experience From the United Kingdom and Ireland.
    Circulation. 2016;134:934-44.
    >> Share


  431. Correction to: Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e261.
    >> Share

  432. WIJESURENDRA RS, Liu A, Eichhorn C, Ariga R, et al
    "Lone" Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persist Despite Successful Catheter Ablation.
    Circulation. 2016 Sep 14. pii: CIRCULATIONAHA.116.022931.
    >> Share

    August 2016
  433. PACKER M
    Heart Failure's Dark Secret: Does Anyone Really Care About Optimal Medical Therapy?
    Circulation. 2016;134:629-31.
    >> Share

    July 2016
  434. TAEGTMEYER H
    Failing Heart and Starving Brain: Ketone Bodies to the Rescue.
    Circulation. 2016;134:265-6.
    >> Share

  435. RAJAPAKSE NW, Kuruppu S, Ian Smith A
    Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Circulation. 2016;134:e9-e10.
    >> Share

  436. HUBERS SA, Brown NJ
    Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Circulation. 2016;134:e11-2.
    >> Share

  437. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    >> Share

    May 2016
  438. MCMURRAY JJ
    Disease Management Programs in Cardiology: Extending the Success in Failure.
    Circulation. 2016;133:1836-7.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016